Saltar al contenido
Slide

An understanding of disease processes drives innovation in medicine

Slide

"A thinker sees his own actions as experiments
and questions, as attempts to find out something.
Success and failure are for him answers above all."

Slide

"There is one thing even more vital to science than intelligent
methods; and that is the sincere desire to find out the truth,
whatever it may be."

- Charles Pierce

Slide

"Every great advance in science has issued
from a new audacity of imagination"

- John Dewey

Slide

"Somewhere, something incredible is waiting to be known"

- Carl Sagan

Slide

"There is nothing which can better deserve your patronage
than the promotion of science and literature. Knowledge is in every country the surest basis of public happiness."

- George Washington

Slide

"Learn from yesterday, live for today, hope for tomorrow
The important thing is to not stop questioning."

- Albert Einstein

previous arrow
next arrow

Welcome

Welcome to the website of the CellCOM Research Group. Our group is a translational and clinical research group within the Institute of Biomedical Research of A Coruña (INIBIC), part of the University Hospital Complex A Coruña, which provides a strong clinical basis for laboratory-based research. Our approaches combine in vitro, ex vivo and in vivo models to conduct pre-clinical studies in age-related diseases and cancer. Our group is a multidisciplinary team that includes basic scientists (predoctoral, postdoctoral fellows and technicians) and clinical researchers such as pathologists, dermatologists, radiologists and surgeons.

Our aims are to understand the physiopathology of connexin-linked diseases (cancer, inflammation, tissue degeneration), to design molecules and new drugs that modulate the activity of specific targets and to identify novel markers of disease prevention, diagnosis and disease management.

We are focused on understanding the role of connexins and pannexins in osteoarthritis, skin wound healing in oncological patients, metastasis and resistance to targeted cancer therapies and immunotherapies. Our final goal is to identify effective therapeutic targets to design specific and successful therapeutic approaches to treat these disorders.

Follow us on Twitter to stay updated on news


Marta visited UCD Conway in Dublin

Marta visited UCD Conway in Dublin

Nov 30, 2016

September 2016    Marta visited Alfonso Blanco lab and the Flow Cytometry Core in UCD Conway for 3 months. She is now an expert in flow cytometry assays. They…

New results published in the MOLECULAR & CELLULAR PROTEOMICS

New results published in the MOLECULAR & CELLULAR PROTEOMICS

Nov 12, 2016

This research work was led by Maria Mayan, performed in collaboration with the Proteomics Unit of INIBIC and Confocal Microscopy Unit of CNIO. It was partially funded by the Francisco…

New results published in ONCOTARGET

New results published in ONCOTARGET

Sep 1, 2016

September 2016    This research work was performed in collaboration with Christian Naus’s lab from The Life Sciences Institute (University of British Columbia, Vancouver, Canada) ONCOTARGET Congrats Rachel!

We got the first position for the all areas of biological science and biomedicine

We got the first position for the all areas of biological science and biomedicine

Jun 13, 2016

June 2016 We got the first position for the all areas of biological science and biomedicine, after the second round (evaluation), of the most competitive predoctoral fellowships (FPU) in Spain.…

The second Thesis Defence of the Group

The second Thesis Defence of the Group

Abr 13, 2016

April 2016 The second Thesis Defence of the Group Congratulations to Dr. Gago!!!

First prize for the career awarded by the BANCO SANTANDER UDC

First prize for the career awarded by the BANCO SANTANDER UDC

Ene 13, 2016

January 2016 Congrats to Marina Rodríguez-Candela for the first prize for the career awarded by the BANCO SANTANDER UDC